Outrage, Praise for CMS ' Proposed Aducanumab Payment Policy Outrage, Praise for CMS ' Proposed Aducanumab Payment Policy

Reaction to the Centers for Medicare& Medicaid Services ' proposed decision to restrict coverage of the controversial and expensive Alzheimer ' s disease drug aducanumab has been swift and polarized.Medscape Medical News
Source: Medscape Neurology and Neurosurgery Headlines - Category: Neurology Tags: Psychiatry News Source Type: news